{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:44Z","timestamp":1740106904513,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82360040"],"award-info":[{"award-number":["No. 82360040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-05961-z","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T03:21:21Z","timestamp":1724728881000},"page":"5627-5638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL"],"prefix":"10.1007","volume":"103","author":[{"given":"Mutibaier","family":"Mijiti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaguli","family":"Abulaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuicui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsheng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guzailinuer","family":"Wufuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"9","key":"5961_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse Large B-Cell Lymphoma. N Engl J Med 384(9):842\u2013858. https:\/\/doi.org\/10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"issue":"2","key":"5961_CR2","first-page":"111","volume":"11","author":"X-Q Li","year":"2012","unstructured":"Li X-Q, Li G-D, Gao Z, Zhou X, Zhu X (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. J Diagn Concepts Pract 11(2):111\u2013115","journal-title":"J Diagn Concepts Pract"},{"issue":"2","key":"5961_CR3","first-page":"239","volume":"128","author":"JM Matthews","year":"2016","unstructured":"Matthews JM, Bhatt S, Patricelli MP, Nomanbhoy TK, Jiang X, Natkunam Y, Gentles AJ, Martinez E, Zhu D, Chapman JR (2016) Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood J Am Soc Hematol 128(2):239\u2013248","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"5961_CR4","first-page":"594","volume":"33","author":"W Xu","year":"2020","unstructured":"Xu W, Liang J (2020) Advances in novel genotyping and molecular targeting therapy for diffuse large B cell lymphoma. J Clin Hematol 33(9):594\u2013598","journal-title":"J Clin Hematol"},{"issue":"2","key":"5961_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg M-L (2017) Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171(2):481-494.e415","journal-title":"Cell"},{"issue":"15","key":"5961_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378(15):1396\u20131407","journal-title":"N Engl J Med"},{"issue":"4","key":"5961_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, Wang JQ, Schmitz R, Morin RD, Tang J, Jiang A (2020) A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell 37(4):551-568.e514","journal-title":"Cancer Cell"},{"issue":"5","key":"5961_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MG, Li AJ, Ziepert M (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24(5):679\u2013690","journal-title":"Nat Med"},{"issue":"15","key":"5961_CR9","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/cncr.32866","volume":"126","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Koff JL, Switchenko JM, Jhaney CI, Harkins RA, Patel SP, Dave SS, Flowers CR (2020) Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. Cancer 126(15):3493\u20133503","journal-title":"Cancer"},{"issue":"2","key":"5961_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10428194.2012.708751","volume":"54","author":"CR Flowers","year":"2013","unstructured":"Flowers CR, Shenoy PJ, Borate U, Bumpers K, Douglas-Holland T, King N, Brawley OW, Lipscomb J, Lechowicz MJ, Sinha R (2013) Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma 54(2):268\u2013276","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"5961_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/10428194.2020.1839656","volume":"62","author":"D Blansky","year":"2021","unstructured":"Blansky D, Fazzari M, Mantzaris I, Rohan T, Hosgood HD (2021) Racial and ethnic differences in diffuse large B-cell lymphoma survival among an underserved, urban population. Leuk Lymphoma 62(3):581\u2013589","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"5961_CR12","doi-asserted-by":"publisher","first-page":"9177","DOI":"10.7314\/APJCP.2014.15.21.9177","volume":"15","author":"X Gu","year":"2014","unstructured":"Gu X, Shen Y, Fu L, Zuo H-Y, Yasen H, He P, Guo X-H, Shi Y-W, Yusufu M (2014) Polymorphic variation of inflammation-related genes and risk of non-Hodgkin lymphoma for Uygur and Han Chinese in Xinjiang. Asian Pac J Cancer Prev 15(21):9177\u20139183","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"5961_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4103\/0973-1482.144357","volume":"11","author":"C-D Jia","year":"2015","unstructured":"Jia C-D, Liang L-P, Yang L-L, Yue N, Zhao F, Bai J-P (2015) Immunological subtypes analysis of Uygur diffuse large B-cell lymphoma in Xinjiang and their prognostic significance. J Cancer Res Ther 11(4):852\u2013856","journal-title":"J Cancer Res Ther"},{"issue":"12","key":"5961_CR14","first-page":"1186","volume":"24","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li X (2018) Relationship of HLA-DPA1, DPB1 Gene Polymorphisms with Hodgkin\u2019s Lymphoma in Uyghur Population. J Chin Oncol 24(12):1186\u20131190","journal-title":"J Chin Oncol"},{"key":"5961_CR15","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 2. International agency for research on cancer, Lyon"},{"issue":"1","key":"5961_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"20","key":"5961_CR17","first-page":"2375","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood J Am Soc Hematol 127(20):2375\u20132390","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"5961_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-L\u00f3pez A, Hagenbeek A (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol 17(4):1244\u20131244","journal-title":"J Clin Oncol"},{"issue":"19","key":"5961_CR19","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.7150\/thno.34070","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L, Ding N, Tong X, Li J, Zhang Y, Wang X, Xu X, Ye M, Li C, Wu X, Bao H, Zhang X, Hong Q, Song Y, Shao YW, Bai C, Zhou J, Hu J (2019) Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics 9(19):5532\u20135541. https:\/\/doi.org\/10.7150\/thno.34070","journal-title":"Theranostics"},{"issue":"13","key":"5961_CR20","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","volume":"24","author":"Z Yang","year":"2018","unstructured":"Yang Z, Yang N, Ou Q, Xiang Y, Jiang T, Wu X, Bao H, Tong X, Wang X, Shao YW, Liu Y, Wang Y, Zhou C (2018) Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. Clin Cancer Res 24(13):3097\u20133107. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2310","journal-title":"Clin Cancer Res"},{"issue":"20","key":"5961_CR21","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1097\/CM9.0000000000001097","volume":"133","author":"RY Li","year":"2020","unstructured":"Li RY, Liang ZY (2020) Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response. Chin Med J (Engl) 133(20):2476\u20132485. https:\/\/doi.org\/10.1097\/CM9.0000000000001097","journal-title":"Chin Med J (Engl)"},{"issue":"14","key":"5961_CR22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"issue":"9","key":"5961_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303. https:\/\/doi.org\/10.1101\/gr.107524.110","journal-title":"Genome Res"},{"issue":"3","key":"5961_CR24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22(3):568\u2013576. https:\/\/doi.org\/10.1101\/gr.129684.111","journal-title":"Genome Res"},{"issue":"1","key":"5961_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","volume":"8","author":"R Shen","year":"2023","unstructured":"Shen R, Fu D, Dong L, Zhang M-C, Shi Q, Shi Z-Y, Cheng S, Wang L, Xu P-P, Zhao W-L (2023) Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal Transduct Target Ther 8(1):145","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5961_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-022-00924-0","volume":"7","author":"J Wei","year":"2022","unstructured":"Wei J, Xiao M, Mao Z, Wang N, Cao Y, Xiao Y, Meng F, Sun W, Wang Y, Yang X (2022) Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT. Signal Transduct Target Ther 7(1):101","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"5961_CR27","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/cncr.25765","volume":"117","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy PJ, Malik N, Nooka A, Sinha R, Ward KC, Brawley OW, Lipscomb J, Flowers CR (2011) Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 117(11):2530\u20132540","journal-title":"Cancer"},{"issue":"3","key":"5961_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41375-023-02120-7","volume":"38","author":"W Ren","year":"2024","unstructured":"Ren W, Wan H, Own SA, Berglund M, Wang X, Yang M, Li X, Liu D, Ye X, Sonnevi K (2024) Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38(3):610\u2013620. https:\/\/doi.org\/10.1038\/s41375-023-02120-7","journal-title":"Leukemia"},{"issue":"25","key":"5961_CR29","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1200\/JCO.23.00570","volume":"41","author":"LK Hilton","year":"2023","unstructured":"Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JC, Cruz M, Roth A, Boyle M (2023) Relapse timing is associated with distinct evolutionary dynamics in diffuse large B-cell lymphoma. J Clin Oncol 41(25):4164\u20134177. https:\/\/doi.org\/10.1200\/JCO.23.00570","journal-title":"J Clin Oncol"},{"issue":"19","key":"5961_CR30","first-page":"1244","volume":"41","author":"B Zhao","year":"2014","unstructured":"Zhao B, Li X, Liu W, Li Y, Zhao Z, Yang S (2014) Difference of Bcl-6 and c-myc gene translocation between Xinjiang Uygur and Han diffused large B-cell lymphoma subtypes. Chin J Clin Oncol 41(19):1244\u20131248","journal-title":"Chin J Clin Oncol"},{"issue":"6","key":"5961_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.20892\/j.issn.2095-3941.2021.0193","volume":"19","author":"Y Qin","year":"2022","unstructured":"Qin Y, Chen H, Liu P, Zhang C, Yang J, Gui L, He X, Zhou L, Zhou S, Jiang S (2022) Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP. Cancer Biol Med 19(6):893","journal-title":"Cancer Biol Med"},{"issue":"19","key":"5961_CR32","first-page":"3986","volume":"120","author":"ZY Xu-Monette","year":"2012","unstructured":"Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu W-m, Montes-Moreno S, Dybk\u00e6r K, Chiu A, Orazi A (2012) Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood J Am Soc Hematol 120(19):3986\u20133996","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"5961_CR33","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1002\/ijc.33049","volume":"147","author":"S Jiang","year":"2020","unstructured":"Jiang S, Qin Y, Jiang H, Liu B, Shi J, Meng F, Liu P, Yang J, Yang S, He X (2020) Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup. Int J Cancer 147(9):2611\u20132620","journal-title":"Int J Cancer"},{"key":"5961_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.critrevonc.2015.08.006","volume":"97","author":"T-X Lu","year":"2016","unstructured":"Lu T-X, Young KH, Xu W, Li J-Y (2016) TP53 dysfunction in diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 97:47\u201355","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"5961_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","volume":"32","author":"K Karube","year":"2018","unstructured":"Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ord\u00f3\u00f1ez G, Rovira J, Clot G, Royo C (2018) Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia 32(3):675\u2013684","journal-title":"Leukemia"},{"issue":"7","key":"5961_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/ijc.30838","volume":"141","author":"T Zenz","year":"2017","unstructured":"Zenz T, Kreuz M, Fuge M, Klapper W, Horn H, Staiger AM, Winter D, Helfrich H, Huellein J, Hansmann ML (2017) TP53 mutation and survival in aggressive B cell lymphoma. Int J Cancer 141(7):1381\u20131388","journal-title":"Int J Cancer"},{"issue":"2","key":"5961_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12920-019-0484-9","volume":"12","author":"EN Voropaeva","year":"2019","unstructured":"Voropaeva EN, Pospelova TI, Voevoda MI, Maksimov VN, Orlov YL, Seregina OB (2019) Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma. BMC Med Genom 12(2):35\u201344","journal-title":"BMC Med Genom"},{"issue":"4","key":"5961_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ajh.26835","volume":"98","author":"JM Michot","year":"2023","unstructured":"Michot JM, Quivoron C, Sarkozy C, Danu A, Lazarovici J, Saleh K, El-Dakdouki Y, Goldschmidt V, Bigenwald C, Dragani M (2023) Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. Am J Hematol 98(4):645\u2013657","journal-title":"Am J Hematol"},{"issue":"59","key":"5961_CR39","doi-asserted-by":"publisher","first-page":"99237","DOI":"10.18632\/oncotarget.18502","volume":"8","author":"DM Greenawalt","year":"2017","unstructured":"Greenawalt DM, Liang WS, Saif S, Johnson J, Todorov P, Dulak A, Enriquez D, Halperin R, Ahmed A, Saveliev V (2017) Comparative analysis of primary versus relapse\/refractory DLBCL identifies shifts in mutation spectrum. Oncotarget 8(59):99237","journal-title":"Oncotarget"},{"issue":"21","key":"5961_CR40","first-page":"2193","volume":"140","author":"L De Leval","year":"2022","unstructured":"De Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies A, Dogan A, Fitzgibbon J, Horwitz SM, Melnick AM, Morice WG (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood J Am Soc Hematol 140(21):2193\u20132227","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"5961_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2013.281","volume":"109","author":"M Katoh","year":"2013","unstructured":"Katoh M (2013) Functional and cancer genomics of ASXL family members. Br J Cancer 109(2):299\u2013306","journal-title":"Br J Cancer"},{"issue":"3","key":"5961_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J, Cui B-W, Wang N, Dai Y-T, Zhang H, Wang C-F, Zhong H-J, Cheng S, Ou-Yang B-S, Hu Y (2020) Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell 37(3):403-419.e406","journal-title":"Cancer Cell"},{"key":"5961_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00205-4","volume":"8","author":"Q Li","year":"2020","unstructured":"Li Q, Zhang W, Li J, Xiong J, Liu J, Chen T, Wen Q, Zeng Y, Gao L, Gao L (2020) Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK\/T-cell lymphoma. Biomark Res 8:1\u201312","journal-title":"Biomark Res"},{"issue":"1","key":"5961_CR44","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1080\/13102818.2019.1657039","volume":"33","author":"B Ma","year":"2019","unstructured":"Ma B, Wu J, Ma B (2019) Association between single nucleotide polymorphism of BRCA1-interacting protein C-terminal helicase 1 and early-onset breast cancer in Uygur and Han women in Xinjiang of China. Biotechnol Biotechnol Equip 33(1):1750\u20131756. https:\/\/doi.org\/10.1080\/13102818.2019.1657039","journal-title":"Biotechnol Biotechnol Equip"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05961-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05961-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05961-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:07:56Z","timestamp":1735866476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05961-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5961"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05961-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Xinjiang Uygur Autonomous Region People's Hospital (KY2022090201). Written informed consent was obtained from each patient before sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent form was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"QPS CCL and YS are employees of Nanjing Geneseeq Technology Inc. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}